It's the first of several new rules banning surprise billing under the No Surprises Act.
from Section Page News - Modern Healthcare https://ift.tt/3dAmaFM
Health tips in Tamil and English & more unique news updates too, " Health is wealth " so, Read data and be strong and healthy!!
It's the first of several new rules banning surprise billing under the No Surprises Act.
CMS' 2022 end-stage renal disease prospective payment system proposal also updates payment rates and delays quality reporting for dialysis providers.
The healthcare industry is now in recovery mode but still adjusting to a new way of doing business.
Northwestern inventor John Rogers has unveiled a wireless pacemaker that can dissolve in the body once its work is done.
The device, detailed by Rogers and colleagues at Northwestern and George Washington University in a study for the journal Nature Biotechnology, naturally can absorb into the body over five to seven weeks and is meant for patients who need only temporary help in regulating their heartbeat. Many patients need pacemakers for only a few days or weeks, either while waiting for a permanent pacemaker or after a procedure such as open-heart surgery.
Current pacemakers can pose an infection risk when used temporarily, and heart tissue can also become damaged when the device is removed.
The device is powered by wireless technology similar in what’s used in the wireless charging of smartphones. It’s made of materials including magnesium, tungsten and iron, which are compatible with the body and are naturally absorbed over time.
"Iron and magnesium are natural, and there's even a recommended daily allowance for them,” Rogers said. “We take supplements containing them."
In addition to testing the device on the hearts of mice and rabbits, colleagues at George Washington were able to test the pacemaker on a donor heart organ, showing that "it can deliver enough pacing power on the human scale,” said Rogers.
With this first paper published, the timeline for potential FDA approval of the device is still about five to seven years away, said Rogers. The device build upon work beginning in 2018 on bioresorbable technology, which has enormous implications for the future of medical devices. In the future, they could help monitor transplant patients and those with traumatic brain injuries.
“The transient electronics platform opens an entirely new chapter in medicine and biomedical research," said GW's Igor Efimov, who co-led the study with Rogers.
Four statewide health plans and one multi-regional plan will now handle care for roughly 1.6 million of the nearly 2.5 million consumers covered by Medicaid.
More than 123,000 low-income people already have been approved for Medicaid coverage in Oklahoma, a state where nearly 15% of the population has been uninsured — the highest rate in the nation behind Texas.
The FDA has not detailed how the 2030 target came about, or why such a distant deadline was granted for a drug that could add billions to the nation's healthcare bill.
The hospital's registered nurses claim they have had more work pushed on them due to a lack of patient sitters, lab technicians and patient care assistants or medical assistants.
Modern Healthcare Hospital Operations Reporter Alex Kacik and Insurance Reporter Nona Tepper discuss why more Americans are bypassing their insurance coverage at the prescription counter.